We are live on ! Find out more
DRNA

Dicerna Pharmaceuticals, Inc.
DRNA

Delisted

DRNA was delisted on the 27th of December, 2021.

Back to rankings

1 hedge funds and large institutions have $76K invested in Dicerna Pharmaceuticals, Inc. in 2021 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 170 closing their positions.

New
Increased
Maintained
Reduced
Closed

265% more call options, than puts

Call options by funds: $73K | Put options by funds: $20K

99% less funds holding

Funds holding: 173 → 1 (-172)

100% less capital invested

Capital invested by funds: $1.25B → $76K (-$1.25B)

100% less funds holding in top 10

Funds holding in top 10: 5 → 0 (-5)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 170

Holders
1
Holders Change
-172
Holders Change %
-99.42%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
170
Calls
$73K
Puts
$20K
Net Calls
+$53K
Net Calls Change
-$10.6M

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
RI
RTW Investments
New York
-$153M
2
BlackRock
BlackRock
New York
-$116M
3
State Street
State Street
Massachusetts
-$78.3M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$74.7M
5
BCLSI
Bain Capital Life Sciences Investors
Massachusetts
-$62.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
CAM
1
Close Asset Management
United Kingdom
$76K – – –
RI
2
RTW Investments
New York
– -$153M -7,582,396 Closed
BlackRock
3
BlackRock
New York
– -$116M -5,763,585 Closed
State Street
4
State Street
Massachusetts
– -$78.3M -3,886,181 Closed
Vanguard Group
5
Vanguard Group
Pennsylvania
– -$74.7M -3,707,210 Closed
BCLSI
6
Bain Capital Life Sciences Investors
Massachusetts
– -$62.1M -3,080,237 Closed
T. Rowe Price Associates
7
T. Rowe Price Associates
Maryland
– -$54.1M -2,682,596 Closed
ACM
8
Aquilo Capital Management
California
– -$49.5M -2,456,595 Closed
Morgan Stanley
9
Morgan Stanley
New York
– -$35M -1,736,277 Closed
JP Morgan Chase
10
JP Morgan Chase
New York
– -$31.1M -1,542,476 Closed
WP
11
Woodline Partners
California
– -$27.3M -1,352,048 Closed
Assenagon Asset Management
12
Assenagon Asset Management
Luxembourg
– -$27.2M -1,350,558 Closed
MC
13
Maverick Capital
Texas
– -$26.4M -1,310,530 Closed
PCH
14
Polar Capital Holdings
United Kingdom
– -$26.2K -1,299,372 Closed
CC
15
Commodore Capital
New York
– -$26.1M -1,292,251 Closed
EC
16
EcoR1 Capital
California
– -$25.2M -1,249,812 Closed
Geode Capital Management
17
Geode Capital Management
Massachusetts
– -$24M -1,190,676 Closed
UBS Group
18
UBS Group
Switzerland
– -$22.2M -1,101,275 Closed
PAI
19
Palo Alto Investors
California
– -$17.3M -855,713 Closed
PAMS
20
Pictet Asset Management (Switzerland)
Switzerland
– -$16.3M -806,987 Closed
GPP
21
Great Point Partners
Connecticut
– -$16.1M -799,999 Closed
Goldman Sachs
22
Goldman Sachs
New York
– -$16.1M -798,544 Closed
Two Sigma Advisers
23
Two Sigma Advisers
New York
– -$15.4M -765,550 Closed
Northern Trust
24
Northern Trust
Illinois
– -$15.4M -764,310 Closed
EAM
25
Eagle Asset Management
Florida
– -$14.3M -709,674 Closed
1
2 3 4 5

DRNA Hedge Fund Activity: Q4 2021 in Review

1 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Dicerna Pharmaceuticals, Inc. (DRNA) for Q4 2021, worth a combined $76K — down 100% from $1.25B a quarter earlier.

Sellers outnumbered buyers: 170 funds closed out of DRNA and 0 opened new positions — a net loss of 170 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was RTW Investments, exiting entirely with an estimated $153M sold.

  • 1 institutional investor held Dicerna Pharmaceuticals, Inc. (DRNA) as of Q4 2021, down from 173 in Q3 2021.
  • Funds reported $76K of Dicerna Pharmaceuticals, Inc. stock for Q4 2021, down 100% quarter-over-quarter.
  • 0 funds opened new Dicerna Pharmaceuticals, Inc. positions in Q4 2021 and 170 closed out, a net change of -170 holders.
  • The largest Dicerna Pharmaceuticals, Inc. seller in Q4 2021 was RTW Investments, an estimated $153M sold.

Based on aggregated 13F filings for Q4 2021.